DIFFERENTIATED THYROID CANCER
Clinical trials for DIFFERENTIATED THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new DIFFERENTIATED THYROID CANCER trials appear
Sign up with your email to follow new studies for DIFFERENTIATED THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced thyroid cancer: personalized drug cocktails tested
Disease control Not yet recruitingThis early-phase trial tests whether giving advanced thyroid cancer patients a personalized mix of already-approved drugs, chosen based on their tumor's genetic profile, is feasible and safe. Ten patients with no other treatment options will receive individualized drug combinatio…
Matched conditions: DIFFERENTIATED THYROID CANCER
Phase: PHASE1 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a second dose of radioactive iodine catch hidden thyroid cancer?
Disease control Not yet recruitingThis study tests whether giving more radioactive iodine can help people with differentiated thyroid cancer whose tumor marker (thyroglobulin) is high but whose scans show nothing. One hundred adults who have already had their thyroid removed and one round of radioactive iodine wi…
Matched conditions: DIFFERENTIATED THYROID CANCER
Phase: PHASE1, PHASE2 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New drug cocktail aims to shrink Hard-to-Treat thyroid tumors
Disease control Not yet recruitingThis phase II trial tests two drugs—anlotinib and benmelstobart—as a second-line treatment for people with advanced or metastatic differentiated thyroid cancer that has not responded to first-line therapy. The study will enroll 23 participants and measure how many see their tumor…
Matched conditions: DIFFERENTIATED THYROID CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Thyroid cancer trial tests faster hormone control after radioiodine
Disease control Not yet recruitingThis study will enroll 40 people with high-risk differentiated thyroid cancer who need radioactive iodine therapy. After stopping their own thyroid hormones, participants will receive either standard levothyroxine alone or levothyroxine plus liothyronine. The goal is to see which…
Matched conditions: DIFFERENTIATED THYROID CANCER
Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC